Cancer Genomics

Evidence-based educational resources for healthcare providers on cancer genomic topics.

BRCA1/BRCA2 Hereditary Breast and Ovarian Cancer Syndrome 

GEC-KO on the run: A 2-page, evidence-based summary for healthcare providers.  Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing. (Updated April 2016)

GEC-KO Messenger: A 10-page, comprehensive evidence-based resource for healthcare providers.  Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing, references and more.  (Updated April 2016)

Point of Care tool: A two-part (I, II) tool to identify individuals likely to benefit from a genomic risk assessment (I) and those predicted to be at increased risk to carry a mutation in the BRCA1 or BRCA2 genes (II). (Updated July 2019)

Lynch Syndrome (Hereditary colorectal cancer)

GEC-KO on the run: A 3-page, evidence-based summary for healthcare providers.  Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing. (Updated Jan 2019)

GEC-KO Messenger: A 9-page, comprehensive evidence-based resource for healthcare providers.  Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing, references and more.  (Updated Jan 2019)

Point of care tool: A two-part (I, II) tool containing three questions to stratify an individual’s risk for hereditary colorectal cancer and to identify those that likely to benefit from a genomic assessment (I), as well as those at high risk to carry a mutation in a Lynch syndrome gene (II).   (Updated Oct 2014).